Join
Live feed
·
INSIDERFilingvia Quantisnow
CRISPR Therapeutics AG logo

Director Behbahani Ali acquired 75 shares, increasing direct ownership by 23% to 316 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CRSP· CRISPR Therapeutics AG
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CRSP (CRISPR Therapeutics AG) and more on Quantisnow.